Latest News

All the news from Anaphylaxis UK

Looking for Allergy Alerts?

Allergy Alerts

Latest News from Anaphylaxis UK

Support for adults with food and non-food allergy 10th July 2026

Food and non-food allergies are often associated with childhood, but millions of adults across the UK live with allergies too. Around 6% of the UK adult population has a clinically confirmed food allergy, equating to approximately 2.4 million people[1]. Many
[…]

Read more
Lower dose EURneffy® nasal adrenaline spray approved by MHRA for younger children 30th June 2026

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a lower-dose version of the adrenaline nasal spray, EURneffy®, for the emergency treatment of serious allergic reactions (anaphylaxis) in children aged four years and over. This adrenaline device option is
[…]

Read more
Anaphylaxis UK welcomes launch of Natasha’s Prize 22nd June 2026

The announcement that Natasha’s Foundation has launched Natasha’s Prize – a groundbreaking £10 million fund dedicated to research into preventing allergies – has been hugely encouraging for the allergy community.  As a charity supporting people living with serious allergies, Anaphylaxis UK warmly
[…]

Read more

News Type:

Meeting the Challenges of the National Allergy Crisis report 1st November 2021

The All Party Parliamentary Group for Allergy in conjunction with the National Allergy Strategy Group (NASG) has launched a report “Meeting the Challenges of the National Allergy Crisis” which calls for an influential lead for allergy to be appointed who

Read more
All Party Parliamentary Group for Allergy launch new report on the “National Allergy Crisis” 28th October 2021

The All Party Parliamentary Group for Allergy in conjunction with the National Allergy Strategy Group (NASG) are today launching a report “Meeting the Challenges of the National Allergy Crisis” which calls for an influential lead for allergy to be appointed

Read more
Anaphylaxis Campaign welcomes Simon Williams as new Chief Executive 18th October 2021

Anaphylaxis Campaign is pleased to announce the appointment of Simon Williams as CEO, as of 22 November 2021.   Simon succeeds Lynne Regent, who retired in August 2021 after 13 years as Chief Executive. Simon was Head of External Affairs

Read more
Statement regarding the inquest of Cason Hallwood 15th October 2021

The senior coroner for Cheshire, Alan Moore, has ended the inquest into the death of 12-year-old Cason Hallwood, who tragically died on Christmas Day 2020. Cason was allergic to nuts and had asthma. He died in hospital following an allergic

Read more
Anaphylaxis Campaign at the BSACI Conference 2021 14th October 2021

The Anaphylaxis Campaign was delighted to attend the annual conference of the British Society for Allergy and Clinical Immunology in Harrogate from the 6th to 9th October 2021 This was the first face-to-face conference for the BSACI in two years

Read more
Imperial College London – Short Courses in Allergy 14th October 2021

At Imperial College London, our courses are run by world-leading experts and incorporate up-to-the-minute information on new research and clinical practice to ensure that what you learn is always relevant to what you do. These innovative online courses will give

Read more
2021 vaccine recommendations for children with food allergy or asthma 14th October 2021

The paediatric allergy group of the British Society for Allergy and Clinical Immunology have produced updated guidance for clinicians about vaccinations against COVID-19, Influenza and MMR for children with food allergy or asthma. You can read the new guidance here 

Read more
New BSACI 2021 guideline for the management of egg allergy 14th October 2021

Egg allergy most commonly presents in infancy and around 1 in 50 children has an egg allergy. An updated guideline for the management of egg allergy has been announced by the British Society for Allergy and Clinical Immunology (BSACI). The

Read more
Research on the economic burden caused by peanut allergy 12th October 2021

Kantar Health, an independent research agency, is collaborating with sponsoring company DBV Technologies, and with the assistance of Anaphylaxis Campaign, to conduct research on the economic burden caused by peanut allergy. In this context, Kantar Health  invite you to participate

Read more